Apotex Health Corp (APTX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 06-2026 | 06-2025 | |
| Cash Flows From Operating Activities | ||
| Depreciation Amortization | 37,651 | 27,917 |
| Income taxes - deferred | 25,214 | 96,658 |
| Accounts receivable | -109,563 | -169,148 |
| Other Working Capital | -152,854 | -61,706 |
| Other Operating Activity | 228,853 | 512,878 |
| Operating Cash Flow | $29,301 | $406,599 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -38,088 | -19,743 |
| Purchase Sale Intangibles | -23,586 | -14,519 |
| Investing Cash Flow | $-61,674 | $-34,262 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 274,696 | N/A |
| Debt Repayment | -840,069 | -55,439 |
| Common Stock Issued | 850,000 | 0 |
| Other Financing Activity | -53,640 | 0 |
| Financing Cash Flow | $230,987 | $-55,439 |
| Exchange Rate Effect | 3,153 | -4,766 |
| Beginning Cash Position | 56,992 | 77,968 |
| End Cash Position | 258,759 | 390,100 |
| Net Cash Flow | $198,614 | $316,898 |
| Free Cash Flow | ||
| Operating Cash Flow | 29,301 | 406,599 |
| Capital Expenditure | -61,674 | -34,262 |
| Free Cash Flow | -32,373 | 372,337 |